Tipifarnib(CAS: 192185-72-1)

Tipifarnib is a crystalline compound with a molecular weight of approximately 414.55 g/mol. Its solubility in water is low, and it is slightly soluble in ethanol. Tipifarnib exhibits good stability in acidic and basic conditions but is reactive towards strong oxidizing agents. It is typically stored at room temperature in a desiccator.

Tipifarnib is synthesized via a multi-step process involving condensation, alkylation, and functional group transformations. Key steps include the synthesis of a piperidine ring and subsequent alkylation at the C20 position of farnesyl pyrophosphate. The reaction typically uses organic solvents and catalysts like palladium, with high selectivity and yield around 80-90%.

Tipifarnib is primarily used in the pharmaceutical industry for the development of cancer treatments. It has shown potential in targeting RAS oncogenes, which are frequently mutated in various cancers. Though less common, it has applications in research for studying protein farnesylation and its role in cellular processes.

When handling Tipifarnib, appropriate personal protective equipment (PPE) is essential, including gloves, protective eyewear, and lab coat. Work should be conducted in a fume hood to minimize exposure. Spills should be cleaned up using appropriate absorbent materials, and the area should be thoroughly ventilated. Always refer to the Safety Data Sheet (SDS) for detailed handling and disposal instructions.